Exhibit 99.1

Gevo Reports Fourth Quarter 2017 Financial Results

- Gevo to Host Conference Call Today at 4:30 p.m. EST/2:30 MST -

ENGLEWOOD, Colo. – March 28, 2018 - Gevo, Inc. (NASDAQ: GEVO) today announced financial results for the three months ended December 31, 2017. Key highlights for the fourth quarter of 2017 and key subsequent events included:

2017 Production and Sales

During 2017 Gevo produced 15.6 million gallons of ethanol, 47 thousand tons of animal feed, and 1,050 tons of corn oil resulting in a revenue of $26.3 million. Consistent with Gevo’s market development efforts, during 2017, Gevo produced approximately 206,000 gallons of isobutanol at its production facility in Luverne, Minnesota (the “Luverne Facility”).  During 2017, Gevo sold the equivalent of approximately 49,368 gallons of isobutanol, either directly as isobutanol or as renewable hydrocarbons (jet fuel, isooctane and isooctene) resulting in revenue of $1.1 million.

Market Development, Sales and Production Strategy for 2018

In 2018, Gevo intends to continue to develop the markets for its isobutanol, jet fuel, isooctane, and other products made from isobutanol and ethanol.  Ultimately, Gevo’s primary target is to enter into binding supply contracts for isobutanol and related hydrocarbon products that represent the majority of the production volumes to be produced at the expanded Luverne Facility that Gevo plans to construct (the “Luverne Facility Expansion”).  The focus for market development continues to be:

Gevo expects to use its inventory of isobutanol to meet its market development needs in 2018.  In 2017, Gevo ran up an inventory of isobutanol.  During the production runs at the Luverne Facility in 2017, Gevo also met its variable cost production targets for isobutanol.  As previously disclosed, running isobutanol at a scale of 1.5 MGPY, the current capacity of the Luverne Facility, costs Gevo cash because not all of the fixed costs are covered given the relatively low run rate.   Gevo is prepared to ramp-up isobutanol production in response to positive demand and price appreciation.   Gevo will be focused on developing markets and generating cash using the current inventory.  Gevo expects to be selling isobutanol into the gasoline blendstock market, as well as selling isooctane, jet fuel and other products made from inventoried isobutanol.

2

NASDAQ Market Price Compliance

On June 21, 2017, Gevo received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market, notifying it that, for the prior 30 consecutive business days, the closing bid price of Gevo’s common stock was not maintained at the minimum required closing bid price of at least $1.00 per share as required for continued listing on the Nasdaq Capital Market. In accordance with Nasdaq Listing Rules, Gevo had an initial compliance period of 180 calendar days, to regain compliance with this requirement. On December 20, 2017, the Nasdaq Stock Market granted Gevo an additional 180 calendar days, or until June 18, 2018, to regain compliance. To regain compliance, the closing bid price of Gevo’s common stock must be $1.00 per share or more for a minimum of 10 consecutive business days at any time before June 18, 2018. The Nasdaq determination to grant the second compliance period was based on Gevo’s meeting of the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and Gevo’s written notice of its intention to cure the deficiency during the second compliance period by effecting a reverse stock split, if necessary.

Financial Highlights

Revenues for the fourth quarter of 2017 were $6.7 million compared with $5.8 million in the same period in 2016. During the fourth quarter of 2017, revenues derived at the Luverne plant were $6.6 million, an increase of approximately $1.2 million from the same period in 2016. This was primarily a result of higher ethanol production and increased distiller grain prices in the fourth quarter of 2017 versus the same period in 2016.

During the fourth quarter of 2017, hydrocarbon revenues were $0.05 million, $0.4 million lower than the same period in 2016. Gevo’s hydrocarbon revenues are comprised of sales of jet fuel, isooctane and isooctene.

Gevo generated grant and other revenue of $0.1 million during the fourth quarter of 2017, an increase of less than $0.05 million as compared to the same period in 2016.

Cost of goods sold was $9.3 million for the three months ended December 31, 2017, compared with $8.2 million in the same quarter in 2016. Cost of goods sold included approximately $7.8 million associated with the production of ethanol, isobutanol and related products and approximately $1.5 million in depreciation expense.

Gross loss was $2.7 million for the three months ended December 31, 2017, versus $2.3 million in the same quarter in 2016.

Research and development expense was $0.9 million during the three months ended December 31, 2017, compared with $1.5 million in the same quarter in 2016.

Selling, general and administrative expense decreased by $1.3 million during the three months ended December 31, 2017, compared with the same quarter in 2016.

Loss from operations in the fourth quarter of 2017 was $4.8 million, compared with $6.5 million in the same quarter in 2016.

Non-GAAP cash EBITDA loss in the fourth quarter of 2017 was $3.1 million, compared with $4.7 million in the same quarter in 2016.

Interest expense in the fourth quarter of 2017 was $0.8 million, down $0.5 million as compared to the same quarter last year.

During the three months ended December 31, 2017, the estimated fair value of the derivative warrant liability increased by less than $0.05 million, resulting in a non-cash loss from a change in the fair value of derivative warrant liability.

During the three months end December 31, 2017, Gevo recognized a $1.2 million gain from the change in fair value of the 2020 Notes embedded derivative.

The net loss for the fourth quarter of 2017 was $4.4 million, compared with $2.3 million during the same period in 2016.

The non-GAAP adjusted net loss for the fourth quarter of 2017 was $5.6 million, compared with $7.8 million during the same period in 2016.

3

The cash position at December 31, 2017 was $11.6 million and the total principal face value of the debt outstanding was $17.2 million.

Webcast and Conference Call Information

Hosting today’s conference call at 4:30 p.m. EST (2:30 p.m. MST) will be Dr. Patrick Gruber, Chief Executive Officer, Bradford Towne, Chief Accounting Officer, and Geoff Williams, General Counsel. They will review Gevo’s financial results and provide an update on recent corporate highlights.

To participate in the conference call, please dial 1(888) 771-4371 (inside the U.S.) or 1 (847) 585-4405 (outside the U.S.) and reference the access code 46437992. A replay of the call and webcast will be available two hours after the conference call ends on March 28, 2018. To access the replay, please dial 1(888) 843-7419 (inside the US) or 1(630) 652-3042 (outside the US) and reference the access code 46437992#. The archived webcast will be available in the Investor Relations section of Gevo's website at www.gevo.com.

About Gevo

Gevo is a leading renewable technology, chemical products, and next generation biofuels company. Gevo has developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstocks. Gevo’s strategy is to commercialize biobased alternatives to petroleum-based products to allow for the optimization of fermentation facilities’ assets, with the ultimate goal of maximizing cash flows from the operation of those assets. Gevo produces isobutanol, ethanol and high-value animal feed at its fermentation plant in Luverne, Minnesota. Gevo has also developed technology to produce hydrocarbon products from renewable alcohols. Gevo currently operates a biorefinery in Silsbee, Texas, in collaboration with South Hampton Resources Inc., to produce renewable jet fuel, octane, and ingredients for plastics like polyester. Gevo is committed to a sustainable bio-based economy that meets society’s needs for plentiful food and clean air and water.

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to a variety of matters, including, without limitation, statements related to the ability of Gevo to develop markets for its products, the ability of Gevo to become profitable, the ability of Gevo to enter into binding offtake, sales or supply agreements for its products, the ability of Gevo to produce isobutanol or related hydrocarbon products at its Luverne, Minnesota production facility, the ability of Gevo to finance the Luverne Facility Expansion, the ability of Gevo to achieve its 2018 operational and financial targets and milestones, the ability of Gevo to secure new customer relationships across core markets, and other statements that are not purely statements of historical fact. These forward-looking statements are made on the basis of the current beliefs, expectations and assumptions of the management of Gevo and are subject to significant risks and uncertainty. Investors are cautioned not to place undue reliance on any such forward-looking statements. All such forward-looking statements speak only as of the date they are made, and Gevo undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise. Although Gevo believes that the expectations reflected in these forward-looking statements are reasonable, these statements involve many risks and uncertainties that may cause actual results to differ materially from what may be expressed or implied in these forward-looking statements. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gevo in general, see the risk disclosures in the Annual Report on Form 10-K of Gevo for the year ended December 31, 2017, and in subsequent reports on Forms 10-Q and 8-K and other filings made with the U.S. Securities and Exchange Commission by Gevo.

4

Non-GAAP Financial Information

This press release contains financial measures that do not comply with U.S. generally accepted accounting principles (GAAP), including non-GAAP cash EBITDA loss and non-GAAP adjusted net loss per share. On a non-GAAP basis, non-GAAP cash EBITDA excludes non-cash items such as depreciation and stock-based compensation. On a non-GAAP basis, non-GAAP adjusted net loss per share excludes non-cash gains and/or losses recognized in the quarter due to the changes in the fair value of certain of Gevo’s financial instruments, such as warrants, convertible debt and embedded derivatives. Management believes these measures are useful to supplements to its GAAP financial statements with this non-GAAP information because management uses such information internally for its operating, budgeting and financial planning purposes. These non-GAAP financial measures also facilitate management's internal comparisons to Gevo’s historical performance as well as comparisons to the operating results of other companies. In addition, Gevo believes these non-GAAP financial measures are useful to investors because they allow for greater transparency into the indicators used by management as a basis for its financial and operational decision making. Non-GAAP information is not prepared under a comprehensive set of accounting rules and therefore, should only be read in conjunction with financial information reported under U.S. GAAP when understanding Gevo’s operating performance. A reconciliation between GAAP and non-GAAP financial information is provided in the financial statement tables below.

Reverse Stock Split

On December 21, 2016, our Board of Directors approved a reverse split of our common stock, par value $0.01, at a ratio of one-for-twenty. This reverse stock split became effective on January 5, 2017 and, unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in this press release and the accompanying consolidated financial statements have, where applicable, been adjusted to reflect this reverse stock split.

5

Gevo, Inc.

Condensed Consolidated Statements of Operations Information

(Unaudited, in thousands, except share and per share amounts)

6

Gevo, Inc.

Condensed Consolidated Balance Sheet Information

(Unaudited, in thousands)

7

Gevo, Inc.

Condensed Consolidated Cash Flow Information

(Unaudited, in thousands)

8

Gevo, Inc.

Reconciliation of GAAP to Non-GAAP Financial Information

(Unaudited, in thousands)

9

Investor and Media Contact

Shawn M. Severson

Integra Investor Relations

+1 415-226-7747

gevo@integra-ir.com

10